ZytoLight ® SPEC MEF2D/BCL9 TriCheckTM Probe

The ZytoLight ® SPEC MEF2D/BCL9 TriCheckTM Probe is designed to detect inversions involving the chromosomal region 1q21.2 harboring the BCL9 gene and the chromosomal region 1q22 harboring the MEF2D gene. Rearrangements of the myocyte enhancer factor 2D (MEF2D) have been frequently found in acute lymphoblastic leukemia (ALL).

Probe Maps


Ordering Information

Prod. No.:Tests¹ (Volume):Registration Status²:
5 (50 µl)

Download Information


1 Using 10 μl probe solution per test.
2 In vitro diagnostic medical device according to EU directive 98/79/EC. 
CE IVD only available in certain countries. All other countries research use only! 
Please contact your local dealer for more information.

ISO 9001
ISO 13485
ZytoVision GmbH


For ZytoVision products additional information is available, which is only valid outside the United States of America (USA). With this action you confirm that you have read this legal notice, that you agree with the terms of use, and that you are not intending to use the information provided on this website within USA.

Accept & Continue